Physician profile
Andre S Colaco
NPI 1366598898
$992.29
in general payments reported to CMS, 2019-2025
18 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $17.30 · 2023: $208 · 2024: $369 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $426.26 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $116.55 | 2023-2025 | Viberzi, Linzess |
| Pfizer INC. | $73.32 | 2023-2024 | |
| Abbott Laboratories | $69.41 | 2020-2024 | Freestyle Libre 3 |
| Amgen INC. | $40.97 | 2019 | |
| Glaxosmithkline, LLC. | $38.29 | 2024 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $29.58 | 2024 | Farxiga |
| Insulet Corporation | $24.63 | 2019 | |
| Tactile Systems Technology INC | $23.87 | 2025 | Flexitouch Plus, Nimbl |
| Neos Therapeutics, Lp | $22.17 | 2023 | Adzenys Xr-Odt |
| Dynavax Technologies Corporation | $18.64 | 2023 | Heplisav-B |
| Resmed Corp | $18.12 | 2024 | |
| Seqirus USA INC | $17.04 | 2019 | |
| Quidel Corporation | $16.62 | 2019 | |
| Beta Bionics, INC. | $16.32 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $14.91 | 2019 | |
| Inspire Medical Systems, INC. | $13.99 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Colaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.